Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the
Oral monilia study on patients with head and neck cancer during radiotherapy
โ Scribed by Tah Yee Chen; John H. Webster
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 318 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Patients with head and neck cancer have to cope not only with a life threatening diagnosis, but also with an altered facial appearance and the loss or impairment of important functions as a result of treatment. As a consequence they are prone to psychosocial problems. Social support might influence
## BACKGROUND. Malnutrition has been recognized as a poor prognostic indicator for cancer treatment-related morbidity and mortality in general, and it is reported to affect 30 -50% of all patients with head and neck cancer. In this study, the correlation of nutritional status with 3-year survival
I strated49 5. 7, 10, 11 that protracted intraarterial Chemotherapy with cytotoxic agents is particularly effective in shrinking or causing transient complete regression in cancer. Rest results have been observed in head and neck, limb, and liver cancer, as the specific vascularization of these area
Background: The aim of this study was to describe prospectively quality of life and mood before and after radiotherapy for laryngeal cancer. Methods: Sixty-five patients with Tis-T3 laryngeal cancer treated with radiotherapy completed the European Organization for Research and Treatment of Cancer (